CoRegen, Inc.
through Feb 26, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | May 22, 2025 · D | Feb 26, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $62,640,000 | $13,500,000 | $-49,140,000 |
| Reported amount sold | $62,640,000 | $13,500,000 | $-49,140,000 |
| Reported investor count | — | — | — |
| Reported minimum investment | $25,000 | $0 | $-25,000 |
Earlier SEC source: 0002012886-25-000003 · Later SEC source: 0002012886-26-000003
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $13,500,000
- Reported amount sold
- $13,500,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20253 filings
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (4)
-
0002012886-26-000003D · Feb 26, 2026 · BiotechnologyOffering: $13,500,000Sold: $13,500,000
-
0002012886-25-000003D · May 22, 2025 · BiotechnologyOffering: $62,640,000Sold: $62,640,000
-
0002012886-25-000002D · Feb 28, 2025 · BiotechnologyOffering: $10,000,002Sold: $10,000,002
-
0002012886-25-000001D · Feb 28, 2025 · BiotechnologyOffering: $20,750,000Sold: $20,750,000